Peer-reviewed veterinary case report
Outcomes of kidney transplants in 15 dogs using triple drug therapy
By Gregory, Clare R et al.·Published in Veterinary surgery : VS·2006·Department of Surgical and Radiological Sciences and Veterinary Medical Teaching Hospital, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy.
- Species:
- dog
Plain-English summary
Fifteen dogs with chronic kidney failure underwent kidney transplants and received a combination of three immunosuppressive drugs to prevent rejection. Unfortunately, nine of the dogs died within a month, mainly due to complications like blood clots. However, three dogs survived for over two years, although they experienced bacterial infections that were treatable with antibiotics. The study suggests that while the immunosuppressive therapy prevented immediate rejection of the new kidney, it also led to a high risk of infections and other issues. Future protocols may need to adjust the level of immunosuppression to improve outcomes.
People also search for: dog kidney transplant complications · chronic kidney failure in dogs · dog infection after surgery
Abstract
OBJECTIVE: To evaluate outcome of renal transplantation in dogs administered cyclosporine, azathioprine, and prednisolone immunosuppression. STUDY DESIGN: Prospective clinical study. ANIMALS: Fifteen dogs with chronic renal failure. RESULTS: Nine dogs died within 1 month of surgery; 5 died from complications associated with generalized thromboembolism. Three dogs survived for 6-25 months. Three dogs alive at the time of this report have survived 22-48 months; however, all 3 dogs have had bacterial infections that responded to antibiotic therapy. There was no biochemical evidence of acute allograft rejection in any dog. Perioperative use of enoxaparin may have prevented thromboembolism in 5 dogs. CONCLUSIONS: Triple drug immunosuppressive therapy used in this study prevented acute renal allograft rejection in 6 dogs that survived >4 weeks; however, immunosuppression was excessive, resulting in an unacceptable frequency of infection and other drug-related complications. Perioperative anticoagulation therapy seem to be warranted. CLINICAL RELEVANCE: Survival time and quality of life for this group of dogs was poor; however, there was no evidence of acute rejection in the dogs surviving >4 weeks. This protocol should only be used if the degree of immunosuppression is reduced, and early evidence of allograft rejection is monitored by renal biopsy or markers of lymphocyte activation.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/16472290/